[go: up one dir, main page]

WO2001092278A3 - Haplotypes of the rlbp1 gene - Google Patents

Haplotypes of the rlbp1 gene Download PDF

Info

Publication number
WO2001092278A3
WO2001092278A3 PCT/US2001/017252 US0117252W WO0192278A3 WO 2001092278 A3 WO2001092278 A3 WO 2001092278A3 US 0117252 W US0117252 W US 0117252W WO 0192278 A3 WO0192278 A3 WO 0192278A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
rlbp1
gene
disclosed
rlbp1 gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/017252
Other languages
French (fr)
Other versions
WO2001092278A2 (en
Inventor
Julie Y Choi
Amir Kazemi
Beena Koshy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001274995A priority Critical patent/AU2001274995A1/en
Publication of WO2001092278A2 publication Critical patent/WO2001092278A2/en
Publication of WO2001092278A3 publication Critical patent/WO2001092278A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Novel genetic variants of the Retinaldehyde-Binding Protein 1 (RLBP1) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the RLBP1 gene. Compositions and methods for haplotyping and/or genotyping the RLBP1 gene in an individual are also disclosed. Polynucleotides defined by the sequence of the haplotypes disclosed herein are also described.
PCT/US2001/017252 2000-05-26 2001-05-29 Haplotypes of the rlbp1 gene Ceased WO2001092278A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001274995A AU2001274995A1 (en) 2000-05-26 2001-05-29 Haplotypes of the rlbp1 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20761800P 2000-05-26 2000-05-26
US60/207,618 2000-05-26

Publications (2)

Publication Number Publication Date
WO2001092278A2 WO2001092278A2 (en) 2001-12-06
WO2001092278A3 true WO2001092278A3 (en) 2002-04-04

Family

ID=22771301

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/017252 Ceased WO2001092278A2 (en) 2000-05-26 2001-05-29 Haplotypes of the rlbp1 gene

Country Status (2)

Country Link
AU (1) AU2001274995A1 (en)
WO (1) WO2001092278A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112023023830A2 (en) * 2021-05-19 2024-02-20 Univ Bern COMPOSITIONS, METHOD FOR PREPARING SAID COMPOSITIONS, REDOX-SENSITIVE CRALBP MUTANT PROTEIN AND NUCLEIC ACID SEQUENCE ENCODING THE SAME

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COTRAN ET AL.: "Analysis of the DNA of patients with retinitis pigmentosa with a cellular retinaldehyde binding protein cDNA", EXP. EYE RES., vol. 51, 1990, pages 15 - 19, XP002906063 *
INTRES ET AL.: "Molecular cloning and structural analysis of the human gene encoding cellular retinaldehyde-binding protein", J. OF BIOL. CHEM., vol. 269, no. 41, October 1994 (1994-10-01), pages 25411 - 25418, XP002906064 *
MAW ET AL.: "Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa", NATURE GENETICS, vol. 17, October 1997 (1997-10-01), pages 198 - 200, XP002906062 *
MORIMURA ET AL.: "Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens", IOVS, vol. 40, no. 5, April 1999 (1999-04-01), pages 1000 - 1004, XP002906061 *

Also Published As

Publication number Publication date
AU2001274995A1 (en) 2001-12-11
WO2001092278A2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
WO2001090122A3 (en) Haplotypes of the ctla4 gene
WO2001092278A3 (en) Haplotypes of the rlbp1 gene
WO2002018414A3 (en) Haplotypes of the bf gene
WO2001077363A3 (en) Haplotypes of the impdh2 gene
WO2001090126A3 (en) Haplotypes of the snap29 gene
WO2001090127A3 (en) Haplotypes of the hoxd3 gene
WO2001087909A3 (en) Haplotypes of the aanat gene
WO2001090118A3 (en) Haplotypes of the edn2 gene
WO2002012499A3 (en) Haplotypes of the ntf3 gene
WO2002032926A3 (en) Haplotypes of the ccbp2 gene
WO2001079240A3 (en) Haplotypes of the rangap1 gene
WO2002050098A3 (en) Haplotypes of the prlr gene
WO2002002580A3 (en) Haplotypes of the etfb gene
WO2001094362A3 (en) Haplotypes of the acp2 gene
WO2002012562A3 (en) Haplotypes of the pla2g1b gene
WO2002090378A3 (en) Haplotypes of the ces2 gene
WO2002030950A3 (en) Haplotypes of the fy gene
WO2002016399A3 (en) Haplotypes of the tacr1 gene
WO2001087907A3 (en) Haplotypes of the osm gene
WO2002042320A3 (en) Haplotypes of the gsr gene
WO2002055534A3 (en) Haplotypes of the f2rli gene
WO2002026766A3 (en) Haplotypes of the sstr4 gene
WO2002094850A3 (en) Haplotypes of the gnrh2 gene
WO2002038586A3 (en) Haplotypes of the il6 gene
WO2001092279A3 (en) Haplotypes of the aldh5 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP